Spontaneous intracerebral hemorrhage (ICH) has a case fatality at 1 month of approximately 40%.1 Survivors of ICH face a risk of recurrent ICH of approximately 1% to 7% per year,2-4 depending on clinical factors (eg, age, hypertension, or anticoagulation), neuroimaging results (eg, lobar location of the ICH, arteriovenous malformation, or associated cerebral microbleeding), and capacity to treat the underlying cause of the ICH.5 Because 85% of cases of spontaneous ICH are caused by cerebral small vessel disease (predominantly hypertensive deep perforator arteriopathy and cerebral amyloid angiopathy), guidelines for the management of ICH emphasize risk assessment, lifestyle management, and maintaining blood pressure below 130/80 mm Hg to prevent recurrent ICH.6
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Hankey GJ. Ischemic Events After Intracerebral Hemorrhage: A New Target for Secondary Prevention. JAMA Neurol. 2021;78(7):795–797. doi:10.1001/jamaneurol.2021.0772
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: